E. G. Isik Et Al. , "Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.," Clinical nuclear medicine , vol.47, no.1, 2022
Isik, E. G. Et Al. 2022. Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.. Clinical nuclear medicine , vol.47, no.1 .
Isik, E. G., Has-Simsek, D., Sanli, O., Sanli, Y., & Kuyumcu, S., (2022). Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.. Clinical nuclear medicine , vol.47, no.1.
Isik, Emine Et Al. "Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.," Clinical nuclear medicine , vol.47, no.1, 2022
Isik, Emine G. Et Al. "Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.." Clinical nuclear medicine , vol.47, no.1, 2022
Isik, E. G. Et Al. (2022) . "Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.." Clinical nuclear medicine , vol.47, no.1.
@article{article, author={Emine Göknur IŞIK Et Al. }, title={Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.}, journal={Clinical nuclear medicine}, year=2022}